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Background Heart rate variability and autonomic nervous system dysfunc-
tion have a recognised value in the assessment of the prognostic of heart dis-
ease and it is well known that variability decreases with age and in heart
failure or ischemic patients, as a predictor for worsen outcome and for an
increase in mortality and morbidity.
Materials and methods We retrospectively investigated 12 lead Holter
ECG monitoring in the past 2 years for ischemic patients aged 50 or older who
had ventricular arrhythmias. We included in our observational study
25 patients, 16 women and 9 men with a mean age of 64,71±9,09. For each of
the participants we evaluated the heart rate variability parameters: SDNN,
SDANN, MSSD, pNN50.
Results Our analysis revealed that there is a good correlation between the
number of ventricular escape beats on a 24 hours monitoring and the heart rate
variability parameters SDNN (y=8,7266x – 757,02 R2=0,8171) and rMSSD
(y=8,6658x – 65,347 R2=0,6395).
Conclusions The results may be a starting point for future research for
improving the prognostic in elderly with cardio-vascular disease, taking into
consideration that both parameters (heart rate variability and ventricular
arrhythmias) may be influenced and improved either by adequate physical
activity or by antiarrhythmic drugs with strong implications in deciding for
primary and secondary prevention.
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Background As right ventricular lead is positioned endocardialy and left
ventricular lead epicardialy, we hypothesized that baseline epi-endo gradient
could predict CRT response.
Method and results We studied 46 patients referred for CRT. Transtho-
racic echocardiography (TTE) was performed for all patients before and one
year after implantation. Offline analysis with speckle tracking imaging (STI)
analysis of LV endocardial and epicardial wall was performed. Specifically,
epi-endo gradient delay (GD) and gradient contraction (GC) measurements
were performed on the septal and lateral LV wall before and one year after
implantation. CRT response was defined as a reduction>15% of LV end sys-
tolic volume one year after CRT.
Results Mean age was 62±11 year-old and mean EF was 26±7%. Twenty-
two patients were classified as responders. Baseline characteristics of patients
with or without CRT response were similar, except for QRS duration. Before
implantation, septal (10±31ms vs. 20±133 ms, p=0.67) and lateral GD
(1±25ms vs. 4±26 ms, p=0.76) were low and similar in both groups. However
lateral GC was higher in CRT responders (–4.05±2.29% vs. –2.38±2.82%,
p=0.009). After multivariate analysis, lateral GC was the best predictor of
CRT response (p=0.013). One year after implantation, septal GD and GC were
comparable in CRT responders or not. However lateral GC significantly
decreased in CRT responders (–4.05±2.29% at baseline vs. –1.86±2.2%,
p<0.01) whereas no changes were observed for non-responders. Finally lateral
GD was significantly increased at one year in CRT non responders 4±26ms at
baseline vs. 18±43 ms, p<0.01).Conclusion: At baseline no significant LV
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epicardial-endocardial delay gradient was observed in patients with CRT
response or not. However lateral epi-endo gradient contraction is highly inde-
pendently associated with CRT response. Finally this gradient was homo-
genezing one year after CRT for responders.
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Background Few data exist about radiation exposure during implantation
of cardiac electrical device. No dose reference levels (DRLs) were reported.
Purpose to define DRLs and to analyze factors related to an increased radi-
ation dose delivered to patients and medical staff. 
Methods the Raypace study is a multicenter, prospective observational reg-
istry. Using a national database, patient demographic, procedural and radiation
data were collected. Fluoroscopy time (FT) and dose-area product (DAP) were
registered. Physician/staff exposure was measured using 2 real-time personal
dosimeters, one worn under the lead apron and the other one worn outside the
apron. Statistical analysis used log-transformation of DAP, FT and DAP/FT
ratio. 
Results A total of 657 procedures from 9 institutions were reviewed. Pace-
maker (PM) and cardioverter-defibrillator (ICD) implantation was performed
in 481 and 176 patients, respectively. A cardiac resynchronization device was
implanted in 153 patients. Fluoroscopy time was similar for PM and ICD
implantations. Median fluoroscopy time was 836, 117 and 101 second and
median DAP was 1410, 150 and 129 cGy.cm2 for biventricular, dual chamber
and ventricular device implantation, respectively. LAO projection, in addition
to AP projection, was used in 47% of the procedures. Five centers out of 9
used collimation. The median Hp (10) effective dose measured outside the
lead apron was 4.6 μSv and 0.1 μSv under the lead apron. 
Regarding CRT implant procedures, four systems out of 6 were responsible for
an increased exposure (p<0.001). DRLs were 2600, 338 and 332 cGy.cm2 for
biventricular, dual chamber and ventricular device implantation, respectively. 
Conclusions DAP reduction was improved with the use of latest gener-
ators but needed customized settings. Biventricular device implantation
was responsible for the highest radiation exposure. However, radiation
exposure during those procedures have decreased as compared to previ-
ously reported values.
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Introduction Transvenous pacing is a relatively safe treatment with a low
complication rate, but serious thromboembolic complications have been
reported to occur in 0.6% to 3.5% of cases. Superior vena cava obstruction
syndrome is generally an uncommon but serious complication occurring in
<0.1% of patients. 
Case report description A 28-year-old lady with history of DDD perma-
nent pacemaker implantation secondary to a cardiac surgery (mitral and aortic
valves replacements). She was unfortunately electrified occasioning a threshold
elevation. An attempt to implant a new endocavitary lead failed , the venog-
raphy showed a partial occlusion of the right subclavicular vein and a total
occlusion of superior vena cava with supleance, confirmed by the angioscanner.
Her ancient leads were already functional; we replace only the pulse generator.
General examination doesn’t revealed features suggestive of superior vena
caval obstruction which was later confirmed by imaging. She was treated by
continuing her long term oral anticoagulation.
Discussion A review of the literature suggests that neither thrombotic nor
fibrotic obstruction in patients with pacemaker leads is strictly related to the
number of abandoned leads, the presence of severed leads, or the time
elapsing from pacemaker implant.
In our case despite anticoagulation for mechanic valve replacement the
occlusion of the VCS occurred. Cardiac surgery, traumatic placement of
ancient leads and latest electrocution probably contributed to this fact.
Conclusions/Implications Superior vena cava obstruction in patients with
transvenous pacing leads, although rare, is a well recognized complication.
One should carefully look for thromboembolic complications during follow-
up in patients with transvenous pacemaker leads, as it has implications for
future management and carries significant morbidity and mortality.
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Radiofrequency catheter ablation (RFA) is the mainstay of therapy for
supraventricular arrhythmias. Conventional radiofrequency catheter ablation
requires the use of fluoroscopy, exposing patients to ionising radiation. The
feasibility and safety of non-fluoroscopic ablation has already been reported
using three-dimensional mapping systems. We are reporting 2 cases of young
patients, for whom a RFA was performed without using Fluoroscopy.
1rt Case: A 20-year old patient, presenting dyspnea and palpitation. Phy-
sical examination was normal. On ECG, a supraventricular tachycardia (SVT)
with long RP and negative P waves in inferior leads was noted. RF ablation
was indicated. Catheters were placed in the right atrium without the need to
use fluoroscopy, guided by Carto 3D system mapping. The electrophysiology
study made the diagnosis of atrial tachycardie arising from the coronary sinus
ostium. The foci was successfully ablated.
2nd Case: A 16-year old patient, consulting for orthodromic reciproting
tachycardia. Physical exmination and transthoracic echocardiography were
unremarkable. Catheters were placed in the right atrium without the need to
use fluoroscopy, guided by Carto 3 D system mapping. Tachycardia was ini-
tiated via atrial pacing. An anterograd left lateral accessory pathway was diag-
nosed. Left atrium was mapped with Carto 3D system through a permeable
foramen ovale. The pathway was ablated. Ablation of SVT without use of
fluoroscopy has a high acute procedural success rate with low incidence of
procedural complication. Use of this technique completely relieves the patient
and healthcare of radiation exposure.
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Purpose PET/CT may be useful in difficult cases to identify endocarditis in
patients (pts) implanted with cardiac devices. The usefulness of PET/CT before
reimplantation after lead extraction for endocarditis has never been studied. We
